Evaluating a Novel, Portable, Self-Administrable Device ("Beacon") That Measures Critical Flicker Frequency as a Test for Hepatic Encephalopathy.

Philip VutienRichard LiRavi KarkarSean A MunsonJames FogartyKara WalterMichael YacoubGeorge N Ioannou

Published in: The American journal of gastroenterology (2023)

Beacon can be self-administered by patients with chronic liver disease and cirrhosis to measure CFF, a validated screening test for minimal hepatic encephalopathy.

Keyphrases

early onset
low cost